- Home >
- Life Sciences >
- Pharmaceutical >
- Pathology >
Cardiac Rhythm Management Devices World Markets
Cardiac Rhythm Management Devices World Markets
- Report price : $ 1 000
- Publication date : May 2004
- Length : 188 pages
Cardiac Rhythm Management Devices World Markets
This report focuses on the U.S. market and worldwide sales and market trends for pacemakers, defibrillators, leads, and other related cardiac rhythm devices. The cardiac rhythm management markets are divided into the segments of: external defibrillators, implantable defibrillators, external pacemakers, implantable pacemakers, and defibrillator and pacemaker electrodes and leads heart failure specialty products.
RELATED REPORTS
Coronary Stents
- $ 3 950
- July 2006
- 255 pages
This report analyzes the worldwide markets for Coronary Stents in US$ Million. The major product segments analyzed are Bare Metal Stents, and Drug Eluting Stents. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia Pacific, and Rest of World. Annual forecasts are pro ...
Industries : Medical Devices, Pathology | Countries : USA, Japan
Respiratory Drugs
- $ 3 950
- July 2006
- 318 pages
This report analyzes the worldwide markets for Respiratory Drugs in US$ Million. The major product segments analyzed are Asthma, Allergic Rhinitis, and COPD (Chronic Obstructive Pulmonary Disease). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of Wo ...
Commercial Insight: Asthma/COPD - ICS/LABA combinations continue to dominate
- $ 15 200
- August 2006
- 168 pages
IntroductionThe respiratory market will continue to experience strong growth for the next 6 years, driven by the expansion of sales in existing classes, the launch of major new products with safety and convenience advantages, and the results of several landmark studies. Despite patent expiries of th ...
Insulin Pumps (External)
- $ 3 850
- June 2006
- 103 pages
This report analyzes the worldwide markets for Insulin Pumps (External) in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2010. The report profiles 15 companies incl ...
Industries : Pathology, Pharmaceutical | Countries : USA, India
Pipeline Insight: Hepatitis C - Protease inhibitors to drive market expansion
- $ 11 400
- June 2006
- 232 pages
IntroductionAn estimated 10 million people in the seven major markets have chronic HCV. The current standard of care, pegylated interferon (Peg-IFN) plus ribavirin (RBV), achieves long-term disease remission in approximately half of those receiving treatment. More efficacious therapies are required ...
Commercial Insight: Antidiabetics - Patent expiries and cost containment initiatives balanced by pipeline products
- $ 15 200
- August 2006
- 216 pages
IntroductionThe diabetes epidemic has contributed to growth in the antidiabetics market over the past few years. Since the prevalence of diabetes continues to increase, the market will further expand. While early therapy is dominated by generically available agents, and the later stages by insulin, ...
Industries : Pathology, Pharmaceutical | Countries : USA, Japan, Germany, Spain, France, Italy, United Kingdom
The World Asthma and COPD Treatment Market, 2006-2011: A Changing Market with Increasing Potential
- $ 3 240
- August 2006
- 137 pages
VISIONGAIN’S LATEST REPORT – ORDER YOUR COPY TODAYThe asthma treatment market is a $15 billion market, driven by an increasing prevalence and yet without a treatment to cure this debilitating disease. All current drugs treat the symptoms but not the underlying cause. It is currently dominated by ...
The World Diabetes Market, 2005-2011
- $ 3 240
- March 2006
- 176 pages
Diabetes effects approximately 170 million people worldwide and is increasing, with the WHO predicting 300 million diabetics by 2025. The US alone has 20.8 million people suffering with diabetes. This equates to approximately 6% of the population. It was the 6th most common cause of death as recorde ...
Industries : Pharmaceutical, Pathology | Countries : USA, Japan
Commercial Insight: Antihypertensives - New challenges for a maturing market
- $ 15 200
- September 2006
- 206 pages
IntroductionDatamonitor expects the antihypertensive market to exceed $40bn by 2015 across the seven major markets, with novel treatments and the market-leading ARBs delivering much of this value. However, significant hurdles exist, and pharmaceutical companies need to carefully design marketing cam ...
Industries : Pharmaceutical, Pathology | Countries : USA, Japan, Germany, Spain, France, Italy, United Kingdom
Pipeline Insight: HIV - Extending treatment options
- $ 11 400
- September 2006
- 222 pages
IntroductionMore people than ever are living with HIV and AIDS in North America and Western Europe. Over the next five years, a great variety of new HIV drugs are expected to reach the market early stage therapies will be simplified by new products that will transform the market. For those with fe ...
Related industries
reportlinker.com © Copyright 2009. All rights reserved